Showing results (2641-2650 of 2,906) with videos related to
Sort By:
Pageof 291
Ebiomedicine|November 5, 2025
Beyond mild, moderate, and severe traumatic brain injury: modelling severity from clinical, neuroimaging, and blood-based indicatorsLindsay D Nelson, Brooke E Magnus, John K Yue, et al.Journal of Neurotrauma|October 27, 2020
Satisfaction with Life after Mild Traumatic Brain Injury: A TRACK-TBI StudyStephanie D Agtarap, Laura Campbell-Sills, Sonia Jain, et al.Leukemia|October 22, 2011
Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphomaS M Ansell, H Tang, P J Kurtin, et al.Cell Cycle (Georgetown, Tex.)|February 1, 2018
Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patientsKei Kawaguchi, Kentaro Igarashi, Tasuku Kiyuna, et al.Obstetrics and Gynecology|August 13, 2019
Women's Preventive Services Initiative's Well-Woman Chart: A Summary of Preventive Health Recommendations for WomenMaureen G Phipps, Sarah Son, Christopher Zahn, et al.Cell Cycle (Georgetown, Tex.)|June 17, 2017
Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomideKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.Human Molecular Genetics|April 13, 2022
Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in Scn2aK1422E miceDennis M Echevarria-Cooper, Nicole A Hawkins, Sunita N Misra, et al.JAMA|March 18, 2015
Diagnostic concordance among pathologists interpreting breast biopsy specimensJoann G Elmore, Gary M Longton, Patricia A Carney, et al.Frontiers in Immunology|September 16, 2024
Rigid crosslinking of the CD3 complex leads to superior T cell stimulationAlfreda D Nelson, Liangyu Wang, Kimberly G Laffey, et al.Annals of Surgical Oncology|May 30, 2026
Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) SubstudyTina J Hieken, Thomas J Flotte, David Zahrieh, et al.Pageof 291